DG Capital Management (Massachusetts)’s AbbVie ABBV Stock Holding History

DG Capital Management (Massachusetts)’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$791K	Sell	12,544 -920	-7%	-$59.6K	0.78%	53
2016 Q2	$834K	Sell	13,464 -23,880	-64%	-$1.46M	0.89%	47
2016 Q1	$2.13M	Sell	37,344 -13,046	-26%	-$727K	2.09%	18
2015 Q4	$2.98M	Sell	50,390 -14,985	-23%	-$863K	2.66%	11
2015 Q3	$3.56M	Buy	65,375 +2,725	+4%	+$177K	2.4%	11
2015 Q2	$4.21M	Buy	62,650 +22,435	+56%	+$1.46M	2.54%	9
2015 Q1	$2.35M	Sell	40,215 -1,270	-3%	-$76.7K	1.42%	34
2014 Q4	$2.71M	Sell	41,485 -7,825	-16%	-$493K	1.57%	30
2014 Q3	$2.85M	Sell	49,310 -2,940	-6%	-$163K	1.74%	20
2014 Q2	$2.95M	Buy	52,250 +12,910	+33%	+$677K	1.68%	24
2014 Q1	$2.02M	Sell	39,340 -37,330	-49%	-$1.89M	1.2%	43
2013 Q4	$4.05M	Sell	76,670 -9,400	-11%	-$462K	2.26%	11
2013 Q3	$3.85M	Sell	86,070 -10,920	-11%	-$484K	2.18%	14
2013 Q2	$4.01M	Buy	+96,990	New	+$4.24M	2.43%	9

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

DG Capital Management (Massachusetts)'s ABBV Position: Q3 2016 in Review

DG Capital Management (Massachusetts) reduced its AbbVie (ABBV) stake by 6.8% in Q3 2016, selling an estimated $59.6K and leaving 12,544 shares worth $791K. The position accounts for 0.78% of the portfolio, ranked #53.

DG Capital Management (Massachusetts) first reported a position in ABBV in Q2 2013 and has held it in 14 quarters since. The position peaked at $4.21M in Q2 2015. 1,653 funds tracked by Wall St. Rank hold ABBV as of Q3 2016.

DG Capital Management (Massachusetts) held 12,544 shares of AbbVie worth $791K as of Q3 2016.
DG Capital Management (Massachusetts) sold 920 AbbVie shares in Q3 2016, an estimated $59.6K.
AbbVie made up 0.78% of DG Capital Management (Massachusetts)'s portfolio in Q3 2016, its #53 holding.
DG Capital Management (Massachusetts) first reported a position in AbbVie in Q2 2013 and has held it in 14 quarters since.
DG Capital Management (Massachusetts)'s AbbVie position peaked at $4.21M in Q2 2015.
1,653 funds tracked by Wall St. Rank held AbbVie as of Q3 2016.

Based on DG Capital Management (Massachusetts)'s 13F filing for Q3 2016, filed 21 Oct 2016.